Story perspectives

AstraZeneca Unveils $15 Billion Investment Plan in China

1/29/2026

Summary

Story summary

AstraZeneca PLC plans to invest $15 billion in China by 2030, its largest investment there.
The announcement coincided with U.K. Prime Minister Keir Starmer's Beijing visit.
The investment will expand manufacturing and research, notably in cell therapies and radioconjugates.
AstraZeneca has faced controversy, including the arrest of its China president.
The company has over a dozen partnerships with Chinese biotech firms and aims to raise its China workforce above 20,000.

1 of 1

Story summary

AstraZeneca PLC plans to invest $15 billion in China by 2030, its largest investment there.
The announcement coincided with U.K. Prime Minister Keir Starmer's Beijing visit.
The investment will expand manufacturing and research, notably in cell therapies and radioconjugates.
AstraZeneca has faced controversy, including the arrest of its China president.
The company has over a dozen partnerships with Chinese biotech firms and aims to raise its China workforce above 20,000.